Klaus Lun
Corporate Officer/Principal bei TECAN GROUP AG
Vermögen: 2 Mio $ am 31.03.2024
Profil
Klaus Lun is currently the Director at Tecan UK Ltd.
and the Executive VP & Head-Life Sciences Business at Tecan Group AG.
He previously worked as the Director-Business Development at Leica Microsystems GmbH from 2007 to 2011, as the Senior Manager-Project at amaxa GmbH from 2002 to 2007, and as the Vice President-Drug Discovery & Bioresearch at Molecular Devices, Inc. from 2011 to 2013.
Dr. Lun has a graduate degree from Eberhard Karls Universität Tübingen, a doctorate degree from Ruprecht-Karls-Universität Heidelberg, and an MBA from the University of Mannheim.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TECAN GROUP AG
0,04% | 31.12.2022 | 5 053 ( 0,04% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Klaus Lun
| Unternehmen | Position | Beginn |
|---|---|---|
| TECAN GROUP AG | Corporate Officer/Principal | 23.05.2013 |
Tecan UK Ltd.
 Tecan UK Ltd. Medical SpecialtiesHealth Technology Tecan UK Ltd. manufacture of automated laboratory instruments and solutions. The company is headquartered in Theale, the United Kingdom. | Director/Board Member | 31.03.2017 |
Ehemalige bekannte Positionen von Klaus Lun
| Unternehmen | Position | Ende |
|---|---|---|
| Molecular Devices, Inc. | Corporate Officer/Principal | 01.01.2013 |
Leica Microsystems GmbH
 Leica Microsystems GmbH Electronic ComponentsElectronic Technology Leica Microsystems GmbH develops and manufactures high precision optical systems. Its products includes microscopes and imaging solutions, modular microscopers for needs. The company was founded in 1849 and is headquartered in Wetzlar, Germany. | Corporate Officer/Principal | 01.01.2011 |
amaxa GmbH
 amaxa GmbH Miscellaneous Commercial ServicesCommercial Services amaxa GmbH researches gene transfer and gene-based medicines to develop causal therapies for the treatment of severe diseases. It focuses on high-end applications for non-viral delivery of genes and transfer of other charged substrates into cells. The company was founded in 1998 and is headquartered in Cologne, Germany. | Corporate Officer/Principal | 01.01.2007 |
Ausbildung von Klaus Lun
| Eberhard Karls Universität Tübingen | Graduate Degree |
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
| University of Mannheim | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TECAN GROUP AG | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Leica Microsystems GmbH
Leica Microsystems GmbH Electronic ComponentsElectronic Technology Leica Microsystems GmbH develops and manufactures high precision optical systems. Its products includes microscopes and imaging solutions, modular microscopers for needs. The company was founded in 1849 and is headquartered in Wetzlar, Germany. | Electronic Technology |
amaxa GmbH
amaxa GmbH Miscellaneous Commercial ServicesCommercial Services amaxa GmbH researches gene transfer and gene-based medicines to develop causal therapies for the treatment of severe diseases. It focuses on high-end applications for non-viral delivery of genes and transfer of other charged substrates into cells. The company was founded in 1998 and is headquartered in Cologne, Germany. | Commercial Services |
| Molecular Devices, Inc. | Health Technology |
Tecan UK Ltd.
Tecan UK Ltd. Medical SpecialtiesHealth Technology Tecan UK Ltd. manufacture of automated laboratory instruments and solutions. The company is headquartered in Theale, the United Kingdom. | Health Technology |
